However, the company's financial results have been pretty strong. And if DexCom can keep that up in its next quarterly update ...

Dexcom is facing scrutiny and class-action lawsuits over alleged safety and accuracy issues with its G7 monitor.

The global digital health market is set to witness a significant growth rate of 20-25% in the next 5 years. increasing adoption of smartphones and wearable devices, rising demand for remote healthcare ...

After dealing with a deployment problem with glucose monitors earlier this year, interim CEO Jake Leach said improving ...

DexCom stock drops 15% despite strong Q3 and raised 2025 revenue outlook, as margin concerns and D7 product issues spark uncertainty for future growth. Read more here.

You can also contact attorney Jonathan Naji, Esq. by calling (484) 270-1453 or by email at [email protected].